| Literature DB >> 20600481 |
Philippe E Laurent1, Hervé Bourhy, Marc Fantino, Paul Alchas, John A Mikszta.
Abstract
In the present pilot study, intradermal ID delivery systems with a BD microneedle from 1 to 3mm in length, and epidermal delivery (BD skin abrader) through abraded skin surface relative to standard intramuscular injection were evaluated. Circulating neutralizing antibodies were measured against the rabies virus after the Vero cells rabies vaccine was administered at D0, D7, D21 and D49. This clinical evaluation in 66 healthy volunteers shows that ID delivery using BD microneedle technology of 1/4 the IM antigen dose is safe, efficient and reliable, resulting in a protective seroconversion rate. In contrast, the epidermal delivery route did not produce an immune response against the rabies vaccine.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20600481 DOI： 10.1016/j.vaccine.2010.06.062
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641